Great to see Tingewick getting this recognition! Tingewick Society raises thousands of pounds each year for local charities including Oxford Hospitals Charity. Help them this weekend as they do the 3 peaks challenge: tingewick-3peaks.raisely.com/?fbclid=IwAR0O… OUH University of Oxford Medical Sciences

Cool new study using bulk RNAseq on pre- and post-BCG immunotherapy tumours from patients with primary high-risk NMIBC can identify molecular subtypes predictive of progression and that tumour subtypes with >> risk of progression had >> immune and lowest tumour purity scores

📣We can't wait for this exciting talk on developing the first aerosol BCG Human Challenge Model delivered by Dr Hazel Morrison from the Jenner Institute! 🧪 Don't miss out. Register now👉 cvnuk.co.uk #CVNUK23 #healthcare #conference #JennerInstitute

BREAKING: This government's cruel plan to send people seeking asylum to Rwanda is UNLAWFUL. This is a HUGE win. The UK wants hope not hostility. theguardian.com/uk-news/2023/j…

Great to see Tingewick recognised for their amazing work for OUH and Oxford Hospitals Charity! They’re a real credit to the University of Oxford Oxford Students Medical Sciences community.

We are thrilled that the wonderful Tingewick Society Tingewick comprised of Oxford Medical Students - were such deserving winners of this very special award 🎉

You did it, Carlos Alcaraz. #Wimbledon

The first man not named Roger Federer, Rafael Nadal, Novak Djokovic or Andy Murray to win the #Wimbledon Gentlemen's Singles since 2002. @CarlosAlcaraz 🆕

BBC reporting a national guide dog shortage But the government have proposed to Shorten guide dog training from 2 years to 6 months Provide an apprentice route for fast track dog training Have guide dog associates to be supervised by actual guide dogs Introduce guide cats

Sarah Blagden Sarah Blagden is leading University of Oxford's Clinical Trials Office first cancer prevention trial to test diabetes drug metformin in patients with the Li Fraumeni Syndrome. Discover how the trial could reduce cancer risk👀 bit.ly/44YSmKA #CCAM #CRUKFunded

NEW: Oxford R21 malaria vaccine receives World Health Organization (WHO) recommendation paving the way for global roll-out. The vaccine developed by Oxford & SerumInstituteIndia demonstrates a high efficacy. The jab could reduce over half a million malaria-related deaths annually. #OxfordVaccine

Enjoying the first debate of day 2 at the Cancer Research UK Early Detection Conference #EDxConf23 ✨

On the bus back from very enjoyable Science and Innovation at Cancer Research UK early detection conference. Take homes for me: the technology is close. But how do we implement these technologies? Bureaucracy is just a part of the issue. We need to think about this early. V inspired now to go back to work!

Proud of Miriam Dixon-Zegeye for presenting her work on the MILI trial - what a 🌟 Science and Innovation at Cancer Research UK #EDxConf23

Love this from Atreyi Chakrabarty … it can certainly feel like I’ve got papers aeroplanes crashing around in my brain when I’m 🥱

Oxford University launches a study into inhaled TB vaccine bbc.in/3U38Gbu

What is the most common type of mutations, causing cancer and genetic diseases? C to T mutations in CpGs: Signature 1. What is the best understood mutational signature? Signature 1. Or is it? Results of over 8 years of our work is finally out! 🧵1/ nature.com/articles/s4158…

Are you mulling your sleep-schedule in preparation to watch the US election results tonight? Owen Winter breaks down when key battleground states are likely to be called and explains why we might have a result quicker than you might think econ.st/4feHiz3

Last before lunch, we hear lightning talks from: Lucy Denly Ludwig Cancer Dimitris Vavoulis OxfordOncology Yi-Jhih Huang OxfordOncology Lucy Goudswaard Bristol Cancer Learn more about their research at the poster session over lunch! #oxcode24